New Research Helps Therapies Get Around, Through Blood-Brain Barrier

Featured In: Academia News | Neuroscience | Human Studies | Health

Monday, October 19, 2024

Loading...

New findings show scientists are developing novel ways to bypass the blood-brain barrier (BBB), a network of blood vessels that prevents more than 95 percent of all chemicals from entering the brain from the bloodstream. The findings, presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health, could form another step toward treating brain disorders and conditions affecting the central nervous system.

While the BBB protects the brain from harmful chemicals, bacteria, and other substances, it poses a significant problem for the delivery of drugs for hard-to-treat diseases such as Alzheimer’s disease and brain cancer. Researchers describe new methods for transporting drugs across the BBB as well as ways to enhance the brain’s own immune response, which is separated from the body’s immune system by the BBB. Additional research describes new roles for the BBB in neurodegenerative disease and the behavioral and cognitive effects of the immune system, despite its physical separation from the central nervous system.

The studies show that:
• Scientists have developed a new delivery system to shuttle drugs across the BBB by hijacking a known protein transport system. This scientific advance potentially allows researchers to develop therapies for hard-to-treat brain diseases (Jean-Paul Castaigne, MD, abstract 185.1).
• In preliminary reports from a clinical trial, a new drug designed to cross the BBB has helped reduce tumor growth in people with gliomas, the most common form of brain cancer (Jan Drappatz, MD, abstract 185.6).

Other recent research findings discussed during the meeting show that:
• Although it is separated from the central nervous system by the BBB, the immune system affects emotionality and cognition (Katherine Nautiyal, see attached speaker’s summary).
• The BBB and cells in the brain that are not nerve cells may be involved in neurodegenerative diseases, including Alzheimer’s disease, multiple sclerosis, and amyotrophic lateral sclerosis. The findings may offer new avenues for future research and therapies (Berislav Zlokovic, MD, PhD, see attached speaker’s summary).
• New research suggests ways to combat diseases like Alzheimer’s disease by boosting the brain’s immune response, which is separated from the body’s immune system by the BBB (Serge Rivest, PhD, see attached speaker’s summary).

“The development of novel ways to cross the blood-brain barrier has considerable potential for treating a host of debilitating and prevalent diseases and disorders,” said press conference moderator John Kessler, MD, of Northwestern University, an expert in stem cell biology and regenerative neuroscience. “Scientific discoveries like those announced today lead to a better understanding of the complexities of the human brain and nervous system and highlight the importance of additional research in this area.”

This research was supported by national funding agencies, such as the National Institutes of Health, as well as private and philanthropic organizations.

Release date: October 18, 2024

Source: Society for Neuroscience

Join the Discussion
Rate Article: Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Research Exchange

Handle With Care

Aug 26

Researchers face the dual challenges of difficult to handle and hard to maintain stem cells.

Six Tips for More Successful Cell Cultures

Aug 18

For those who perform cell culture experiments, it pays to be meticulous. Even seemingly minor handling techniques and lab equipment features can make a difference in achieving success.

Rapid Generation of Assay-ready Serial Dilution Plates Using Two-stage Low Volume Pipetting

Jul 22

Researchers see the benefits of streamlining accurate serial dilution of stock solutions of compounds. By Joby Jenkins, TTP LabTech As the cost of drug development escalates there is a growing requirement to accelerate the R&D cycle and eliminate unwanted off-target drug effects earlier.

Imaging Through the Pipeline

Jun 15

The evolution of live animal imaging technology has helped researchers get a better picture of the drug research process, from target identification to pharmacokinetic studies.

The Future of the FDA: Operating in an Electronic World

Oct 12

Acording to an Axendia reseach study, the FDA is currently shifting its organizational and technology infrastructures to facilitate electronic interactions with the companies it regulates.

Tissue Microarrays - Opening up new opportunities in the Therapeutics sector

Oct 12

Tissue Microarray has become a pivotal cog in the wheel for high throughput studies and is an integral part in the validation process for screening results from discovery platforms for expression studies using various approaches.

Translational Informatics for Systems Biology

Oct 12

A study in which IO Informatics' Sentient software has been applied to integrating and linking a customer's multiple data streams.

De Novo Formula Generation with Sub-ppm Confidence

Oct 12

Novel technology embodied in the micrOTOF allows precise measurement of both accurate mass and True Isotopic Pattern (TIP) over a wide dynamic range, allowing for the implementation of an open access system.

ADP-Glo™: An Ideal Approach to Monitor the Activity of Protein Kinases and Beyond

Oct 16

Because of its versatility (alltypesofsubstrates), robustness (Z’>0.8), rapidperformance, and its ease of use, the luminescence based Kinase Glo® assay platform has gained wide acceptance in many drug screening programs for protein kinase inhibitors.

A Cell-Based, Microplate Format, DELFIA Assay for Determination of the Activation of MAP KinaseSofia

Oct 16

Mitogen-activated protein kinases(MAPK) are activated in response to extracellularsignals or cellular stress. We have set up a cell-based DELFIA®Time-Resolved Fluorescence assay to test compounds or conditions for their ability to modulate cellular stress by the activation of MAPK.

Cell Based Assays for Studying the Effects of Cytotoxic Agents

Oct 16

Apoptosis, DNA fragmentation and cell proliferation are important parameters when studying live cell function, especially, when the effects of cytotoxic agents are under study.

Editorial

26 minutes ago

 

Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register

26 minutes ago

Objectives To describe trends in the numbers of Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008. Design and setting The National Down Syndrome Cytogenetic Register holds details of 26488 antenatal and postnatal diagnoses of Down's syndrome made by all...

Mortality among residents of shelters, rooming houses, and hotels in Canada: 11 year follow-up study

26 minutes ago

Objective To examine mortality in a representative nationwide sample of homeless and marginally housed people living in shelters, rooming houses, and hotels. Design Follow-up study. Setting Canada 1991-2001. Participants 15 100 homeless and marginally housed people enumerated in 1991 census. ...

Request for Entries

Oct 16

Ask the Experts is your chance to get the answers to questions on applications, materials, methods, processes, and technologies. Email you question to bst_web@advantagemedia.com, and the editors of Bioscience Technology will find an appropriate expert to answer it. Watch this space in the future to see the questions your colleagues are posting.

STAY INFORMED: SUBSCRIBE TO

Magazine and E-mail Newsletters

Loading...
E-mail:   

MULTIMEDIA

Video:

Frontiers in Bioscience Learning and Memory Video

Oct 6

How does the brain learn and remember? An academic conference "Frontiers in Bioscience Learning and Memory" was held at City University of Hong Kong on June 16th.

Podcasts:

Allen Institute for Brain Research

Allen Institute for Brain Research

Oct 14

Discussed in this interview are both the mouse brain project and the human cortex project with an emphasis on the importance of these projects to neuroscience research.